Skip to search.
 TSX Down 0.12% TSX Ventures Down 0.18%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
0.65 Down 0.01(1.74%) 9:55AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:0.66
Open:0.65
Bid:0.65 x 4500
Ask:0.65 x 4200
1y Target Est:4.56
Beta:4.27
Next Earnings Date:N/A
Day's Range:0.65 - 0.66
52wk Range:0.36 - 2.54
Volume:117,929
Avg Vol (3m):5,638,970
Market Cap:90.31M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTXDown 1.74%90.31M
ASTMDown 0.90%N/A
BAXDown 0.09%36.63B
OSIRDown 0.57%622.48M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.40
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.29
Quarterly EPS Est (Jun-15) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback